We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal court in Kansas has ruled that a class action antitrust lawsuit against Mylan over marketing and distribution of its EpiPen can go forward. Read More
The FDA is reviewing a Biologics License Application (BLA) for an innovative, first-in-class treatment for potentially fatal Clostridium difficile infections — an enema-delivered human stool transplant. Read More
Only 45 percent of cancer drug trials made their individual participant data (IPD) available to other qualified researchers over the past 10 years, according to a new study. Read More
The Pharmaceutical Research and Manufacturers of America (PhRMA) is incensed about the reconciliation bill the Senate passed on Sunday night, which would permit the government to negotiate with drugmakers on some prescription drug prices for the Medicare program. Read More